ArticleCureus2026
When Medications Harm Muscles: A Case of a Teenager With Acute Rhabdomyolysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhabdomyolysis is a rare but serious adverse effect of isotretinoin therapy, especially when combined with strenuous physical activity. We present a case of drug-induced rhabdomyolysis with secondary intramuscular abscesses in an adolescent. A 16-year-old male on standard-dose isotretinoin presented with a four-day history of right gluteal and thigh pain and fever, without a history of trauma, but with recent intense physical activity. Laboratory tests showed elevated inflammatory markers, creatine kinase, and myoglobinuria. MRI demonstrated extensive myositis with multiple intramuscular and intermuscular abscesses requiring hydration, antibiotics, drug discontinuation, and surgical drainage, leading to full recovery. This case emphasizes the need for early recognition of isotretinoin-associated rhabdomyolysis, particularly in physically active patients. Prompt imaging, cessation of the offending agent, and timely intervention can prevent renal injury and improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.